Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
57.00    2.00 (3.64%)
Bid:
56.00
Ask:
58.00
Spread: 2.00 (3.571%)
Market Cap: £109.36m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Atlantis Water Project Update

29 Apr 2013 07:00

RNS Number : 4262D
Iofina PLC
29 April 2013
 



 

 

29 April 2013

 

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Atlantis Water Project Update

 

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives,

is pleased to provide the following update in respect of its Atlantis Water Project.

Based on initial responses from and discussions with the Montana Department of Natural Resource Conservation ("DNRC") Water Resources Office following their receipt of the Company's water right permit application, the Company has elected to amend its water permit application in an effort to expedite its plan to market 10,000 acre-feet per year (c.200,000 barrels per day) of freshwater in eastern Montana.

The possibility of needing to amend the original application was anticipated and envisioned as part of this process and the Company has decided to amend its application to expedite the application process. The Company's revised application is to develop a water depot for 3,800 acre-feet per year based on customers' needs at the current planned location. The Company has secured strategic locations for the first water pumping station and place of sale for its initial terminal and recently submitted an amended application to reflect this. The Company is actively acquiring additional strategically placed sites, based on demand and ease of transportation, for two additional depots that, together with the initial depot, will total over 10,000 acre-feet per year as planned.

After discussing the status of the application with the central Water Resources Office, the Company was informed that the department removed the original application from its website, but has not terminated the original application. The original application remains valid pending receipt of the amended application.

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.  

 

For further information, please contact:

 

Stuart Eaton, Executive Operations Officer

Iofina plc

Tel: +44(0)7500 042 516

www.iofina.com

 

Dr Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)7747 693 486

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANLPASNDEFF
Date   Source Headline
10th Apr 20129:39 amRNSHolding(s) in Company
5th Apr 20128:05 amRNSPurchase of Production Site & Recycling Initiative
2nd Apr 20125:01 pmRNSHolding(s) in Company
29th Mar 201212:11 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSCorporate Update
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSHalf Yearly Report
9th Aug 20117:00 amRNSTrading Update
30th Jun 20114:42 pmRNSResult of AGM
24th Jun 201111:42 amRNSHolding(s) in Company
8th Jun 20117:00 amRNSAmbrian Partners Appointed Joint Broker to Iofina
7th Jun 20117:00 amRNSIofina Reports Audited Full Year Financials
31st May 20116:03 pmRNSHolding(s) in Company
4th May 20114:32 pmRNSHolding(s) in Company
4th May 20114:29 pmRNSHolding(s) in Company
28th Apr 201112:58 pmRNSHolding(s) in Company
20th Apr 20117:00 amRNSPlacing
13th Apr 20116:28 pmRNSHolding(s) in Company
25th Mar 20117:00 amRNSContract Win
18th Mar 20117:00 amRNSHolding(s) in Company
1st Mar 20113:35 pmRNSHolding(s) in Company
27th Jan 20115:27 pmRNSHolding(s) in Company
12th Jan 20114:40 pmRNSSecond Price Monitoring Extn
12th Jan 20114:35 pmRNSPrice Monitoring Extension
3rd Dec 201012:46 pmRNSOperations Update
19th Oct 20105:30 pmRNSHolding(s) in Company
29th Sep 20109:26 amRNSHolding(s) in Company
28th Sep 20107:01 amRNSInterim Results
28th Sep 20107:00 amRNSAppointment of Finance Director
31st Aug 20107:00 amRNSFourth Extraction and Collection Agreement Signed
16th Jul 20105:57 pmRNSHolding in Company - Replacement
16th Jul 20105:02 pmRNSHoldings in Company
7th Jul 201010:00 amRNSResult of AGM
4th Jun 20107:00 amRNSFinal Results
20th May 20107:00 amRNSNew Agreement Signed and Operations Update
4th May 20107:00 amRNSIssuance of Permit
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.